Vertex Pharmaceuticals Inc. buy Truist Financial Co.
Start price
31.01.24
/
50%
€400.85
Target price
31.01.25
€470.15
Performance (%)
2.03%
Price
07.10.24
€409.00
Summary
This prediction is currently active. With a performance of 2.03%, the BUY prediction by Truist_Financial_Co_ for Vertex Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 31.01.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -2.083% | -2.083% |
iShares Core DAX® | -1.958% | 4.037% |
iShares Nasdaq 100 | 0.272% | 8.670% |
iShares Nikkei 225® | 0.377% | 7.232% |
iShares S&P 500 | 0.370% | 6.511% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Truist Financial Co. from $456.00 to $508.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€432.30
05.08.24
05.08.24
€500.78
05.08.25
05.08.25
-5.39%
07.10.24
07.10.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€332.85
04.10.23
04.10.23
€434.43
04.10.24
04.10.24
24.34%
05.10.24
05.10.24